Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2009 5
2010 1
2018 2
2019 1
2020 4
2021 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Relative age effect: beyond the youth phenomenon.
Joyner PW, Lewis J, Mallon WJ, Kirkendall D, Dawood R, Fagerberg A, Mills FB 4th, Garrett W. Joyner PW, et al. Among authors: fagerberg a. BMJ Open Sport Exerc Med. 2020 Oct 2;6(1):e000857. doi: 10.1136/bmjsem-2020-000857. eCollection 2020. BMJ Open Sport Exerc Med. 2020. PMID: 33088587 Free PMC article.
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.
Hjorth S, Waters S, Waters N, Tedroff J, Svensson P, Fagerberg A, Edling M, Svanberg B, Ljung E, Gunnergren J, McLean SL, Grayson B, Idris NF, Neill JC, Sonesson C. Hjorth S, et al. Among authors: fagerberg a. J Pharmacol Exp Ther. 2020 Sep;374(3):404-419. doi: 10.1124/jpet.120.000037. Epub 2020 Jun 30. J Pharmacol Exp Ther. 2020. PMID: 32605972
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A, Kullingsjö J, Hjorth S, Waters N. Waters S, et al. Among authors: fagerberg a. J Pharmacol Exp Ther. 2020 Jul;374(1):113-125. doi: 10.1124/jpet.119.264226. Epub 2020 May 1. J Pharmacol Exp Ther. 2020. PMID: 32358046
Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study.
Rodriguez-Wallberg KA, Berger AS, Fagerberg A, Olofsson JI, Scherman-Pukk C, Lindqvist PG, Nasiell J. Rodriguez-Wallberg KA, et al. Among authors: fagerberg a. Gynecol Endocrinol. 2019 Apr;35(4):314-319. doi: 10.1080/09513590.2018.1528577. Epub 2019 Jan 9. Gynecol Endocrinol. 2019. PMID: 30626251
No Wound Healing Complications or Recurrences Were Seen and a High Level of Satisfaction Was Reported in Patients Who Underwent Endoscopic Olecranon Bursectomy for Recalcitrant Olecranon Bursitis.
Simpson JR, Fagerberg A, Toledo R, Joyner PW. Simpson JR, et al. Among authors: fagerberg a. Arthrosc Sports Med Rehabil. 2024 Jan 17;6(1):100832. doi: 10.1016/j.asmr.2023.100832. eCollection 2024 Feb. Arthrosc Sports Med Rehabil. 2024. PMID: 38299046 Free PMC article.
17 results